Skip to main content
Mitsubishi's ALS drug available in US
8/11/2017

Radicava, or edaravone, developed by Mitsubishi Tanabe Pharma America to treat amyotrophic lateral sclerosis, is now available in the US following its FDA approval in May.

Full Story: